The Oncology Institute will announce Q3 2025 financial results on November 13, followed by a conference call.
Quiver AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) has announced that it will release its third quarter 2025 financial results after the market closes on November 13, 2025. Following the announcement, the company will hold a conference call at 5:00 p.m. Eastern Time, which can be accessed by phone or through a live webcast on their Investor Relations website. A replay of the call will be available shortly after it concludes and accessible until November 20, 2025. The Oncology Institute, founded in 2007, focuses on providing value-based community oncology care to about 1.9 million patients across over 100 locations in five states, offering specialized services including clinical trials and transfusions.
Potential Positives
- The Oncology Institute is scheduled to release its third quarter 2025 financial results, which indicates ongoing transparency and communication with investors.
- The upcoming financial conference call provides an opportunity for investors to engage directly with the company and gain insights into its operations and performance.
- The company highlights its growth and expansion, with over 100 clinics and affiliate locations across five states, emphasizing its commitment to advancing oncology care.
- TOI serves a large patient population of approximately 1.9 million, showcasing its significant impact in the community oncology space.
Potential Negatives
- Announcement of financial results occurring after market close may indicate a potential concern over performance, which could create uncertainty for investors.
- Focus on an upcoming conference call suggests that the company may be preparing to address significant financial issues or other announcements that could impact investor confidence.
FAQ
When will The Oncology Institute release its Q3 2025 financial results?
The Oncology Institute will release its Q3 2025 financial results on November 13, 2025, after market close.
How can I join The Oncology Institute's conference call?
The conference call can be joined by dialling 1-877-407-0789 or 1-201-689-8562 for international callers.
What is the passcode for the conference call?
The passcode for the live call and the replay is 13756737.
Will there be a replay of the conference call?
Yes, a replay will be available two hours after the call until November 20, 2025.
How can I access the webcast of the conference call?
The webcast can be accessed via the Investor Relations section of The Oncology Institute’s website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOI Insider Trading Activity
$TOI insiders have traded $TOI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $TOI stock by insiders over the last 6 months:
- GROWTH I L.P. M33 has made 0 purchases and 6 sales selling 9,450,000 shares for an estimated $28,416,299.
- BRAD HIVELY has made 0 purchases and 3 sales selling 1,996,358 shares for an estimated $5,754,203.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TOI Hedge Fund Activity
We have seen 65 institutional investors add shares of $TOI stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,044,554 shares (+1160.5%) to their portfolio in Q2 2025, for an estimated $6,241,335
- VANGUARD GROUP INC added 2,530,173 shares (+144.5%) to their portfolio in Q2 2025, for an estimated $5,186,854
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC removed 1,697,750 shares (-85.4%) from their portfolio in Q2 2025, for an estimated $3,480,387
- MARSHALL WACE, LLP added 1,476,946 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,027,739
- CINCINNATI INSURANCE CO removed 1,240,795 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,543,629
- WEXFORD CAPITAL LP added 1,118,679 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,293,291
- GEODE CAPITAL MANAGEMENT, LLC added 893,696 shares (+231.7%) to their portfolio in Q2 2025, for an estimated $1,832,076
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TOI Analyst Ratings
Wall Street analysts have issued reports on $TOI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/21/2025
To track analyst ratings and price targets for $TOI, check out Quiver Quantitative's $TOI forecast page.
$TOI Price Targets
Multiple analysts have issued price targets for $TOI recently. We have seen 2 analysts offer price targets for $TOI in the last 6 months, with a median target of $6.5.
Here are some recent targets:
- David Larsen from BTIG set a target price of $7.0 on 10/21/2025
- Yuan Zhi from B. Riley Securities set a target price of $6.0 on 07/16/2025
Full Release
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after the market close on Thursday, November 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13756737. The replay will be available until Thursday, November 20, 2025.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/ .
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
[email protected]
Investors
ICR Healthcare
[email protected]
